Myiasis: A successful treatment with topical ivermectin

International Journal of Dermatology

Volumn 38, Issue 2, 1999, Pages 142-144

  Victoria, Jairo ^a   Trujillo, Rodolfo ^a   Barreto, Mauricio ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; FLY; HUMAN; MALE; MYIASIS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; ANTIPARASITIC AGENTS; FEMALE; HUMANS; INSECTICIDES; IVERMECTIN; MALE; MIDDLE AGED; MYIASIS; SKIN DISEASES, PARASITIC; TREATMENT OUTCOME;

EID: 0032981229     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00639.x     Document Type: Article

References (16)

1. Hall MJR, Smith KGV. Diptera causing myiasis in man. In: Lane RP, Crosskey RW, eds. Medical Insects and Arachnids. London: Chapman and Hall, 1993: 429-469.
2. Kpea N, Zywocinski C. "Flies in the flesh": a case report and review of cutaneous myiasis. Cutis 1995; 55: 47-48.
3. Duque CS, Marrugo G, Valderrama R. Otolaryngic manifestations of myiasis. Ear Nose Throat J 1990; 69: 619-622.
4. Jelinek T, Nothdurft HD, Rieder N, Loscher T. Cutaneous myiasis: review of 13 cases in travelers returning from tropical countries. lnt J Dermatol 1995; 34: 624-626.
5. Olsen RW, Snowman AM. Avermectin B1a modulation of gamma aminobutyric acid/benzodiazepine receptor binding in mammalian brain. J Neurochem 1985; 44: 1074-1082.
6. Pong SS, Wang CC. The specificity of high affinity binding of avermectin Bia to mammalian brain. Neuropharmacology 1980; 19: 311-317.
7. Sieghart W. Structure and pharmacology of gamma aminobutyric acid-A receptor subtypes. Pharmacol Rev 1995; 47: 181-231.
8. Bennet DG. Clinical pharmacology of ivermectin. JAVMA 1986; 189: 100-103.
9. Youssef MY, Sadaka HA, Eissa MM, et al. Topical application of ivermectin for human ectoparasites. Am J Trop Med Hyg 1995; 53: 652-653.
10. Williams JC, DeRosa A, Nakamura Y, Loyacano AF. Comparative efficacy of ivermectin pour-on, albendazole, oxfendazole and fenbendazole against Ostertagia ostertagi inhibited larvae, other gastrointestinal nematodes and lungworm of cattle. Vet Parasitol 1997; 73: 73-82.
11. Williams JC, Loyacano AF, DeRosa A, et al. A comparison of the efficacy of two treatments of doramectin injectable, ivermectin injectable and ivermectin pour-on against naturally acquired gastrointestinal nematode infections of cattle during a winter-spring grazing season. Vet Parasitol 1997; 72: 69-77.
12. Chijioke CP, Okonkwo PO. Adverse events following mass ivermectin therapy for onchocerciasis. Trans R Soc Trop Med Hyg 1992; 86: 284-286.
13. Macotela-Ruiz E, Peña-Gonzalez G. Tratamiento de la escabiasis con ivermectina por via oral. Gac Med Mex 1993; 129: 201-205.
14. Glaziou P, Nyguyen LN, Moulia-Pelat JP, et al. Efficacy of ivermectin for the treatment of head lice (pediculosis capitis). Trop Med Parasitol 1994; 45: 253-254.
15. Meinking TL, Taplin D, Hermida JL, Pardo R, et al. The treatment of scabies with ivermectin. N Engl J Med 1995; 333: 26-30.
16. Victoria J, Ahumada N, González F. Pediculosis capitis: tratamiento de 100 niños con ivermectina. Acta Terap Dermatol 1997; 20: 99-103.